Drugs / ACTH
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT05279118 Comparator | Apr 2022 → Jul 2024 | infantile spasms | All India Institute of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05279118 ↗ |
| Route | Intramuscular | “The high dose ACTh is 150U/m2 or 6U/kg dose administered IM daily for two weeks.” NCT05279118 ↗ |